Embla Medical hf. (CPH:EMBLA)
30.80
+0.20 (0.65%)
At close: Aug 15, 2025
Embla Medical Revenue
Embla Medical had revenue of $232.42M USD in the quarter ending June 30, 2025, with 7.24% growth. This brings the company's revenue in the last twelve months to $873.51M, up 6.57% year-over-year. In the year 2024, Embla Medical had annual revenue of $854.89M with 8.81% growth.
Revenue (ttm)
$873.51M
Revenue Growth
+6.57%
P/S Ratio
2.36
Revenue / Employee
$215.10K
Employees
4,061
Market Cap
13.12B DKK
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 854.89M | 69.21M | 8.81% |
Dec 31, 2023 | 785.68M | 67.03M | 9.33% |
Dec 31, 2022 | 718.65M | -19.00K | -0.00% |
Dec 31, 2021 | 718.67M | 89.17M | 14.16% |
Dec 31, 2020 | 629.50M | -56.76M | -8.27% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 311.94B |
Coloplast | 27.79B |
Genmab | 23.16B |
Demant | 22.59B |
ALK-Abelló | 5.71B |
H. Lundbeck | 23.52B |
Ambu A/S | 5.83B |
Zealand Pharma | 9.11B |